Invicta Diagnostic Limited IPO Details

Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, pathology, and teleradiology, under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.

Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:

• A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (CT, MRI)
• Three additional hubs (Bhayandar, Byculla, Marol) providing specialized diagnostic services
• Four spokes in Lower Parel, Sewri, Mazgaon, and Kalwa focused on basic imaging (X-ray, ultrasound) and sample collection.

The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.

Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:

• Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
• Specialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels
• Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.

As of May 31, 2025, the company has a network of 5 laboratory doctors, 20 radiologists and 127 well-trained technical staff.

As of May 31, 2025, the company employed 105 permanent employees.